Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and Appalachian adults who smoke cigarettes: A randomized cross-over study

被引:7
|
作者
Keller-Hamilton, Brittney [1 ,2 ,5 ]
Alalwan, Mahmood A. [2 ]
Curran, Hayley [2 ]
Hinton, Alice [2 ,3 ]
Long, Lauren [2 ]
Chrzan, Kirsten [2 ,3 ]
Wagener, Theodore L. [1 ,2 ]
Atkinson, Leanne [2 ,3 ]
Suraapaneni, Sriya [2 ,4 ]
Mays, Darren [2 ]
机构
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Ctr Tobacco Res, Comprehens Canc Ctr, Columbus, OH USA
[3] Ohio State Univ, Coll Publ Hlth, Columbus, OH USA
[4] Ohio State Univ, Coll Arts & Sci, Columbus, OH USA
[5] Ohio State Univ, Comprehens Canc Ctr, Ctr Tobacco Res, 3650 Olentangy River Rd, Columbus, OH 43214 USA
基金
美国国家卫生研究院;
关键词
Cigarettes; health disparities; misuse liability; nicotine; oral nicotine pouches; rural; TOBACCO PRODUCTS; CANCER INCIDENCE; MORTALITY;
D O I
10.1111/add.16355
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and aims: Oral nicotine pouches (ONPs) probably offer reduced harm compared with cigarettes, but independent data concerning their misuse liability are lacking. We compared nicotine delivery and craving relief from ONPs with different nicotine concentrations to cigarettes.Design: This was a single-blind, three-visit (>= 48-hour washout), randomized-cross-over study. Participants were encouraged to complete all study visits in less than 1 month.Setting: The study took place in Rural/Appalachian Ohio.Participants: Participants comprised 30 adults who smoke cigarettes. Participants (mean(age) = 34.5) were 60% men and 90% White.Intervention: Participants who were >= 12-hour tobacco-abstinent used: (1) a 3-mg nicotine concentration ONP, (2) a 6-mg nicotine concentration ONP and (3) usual brand cigarette in separate visits. ONPs (wintergreen Zyn) were used for 30 minutes; cigarettes were puffed every 30 sec for 5 minutes.Measurements: Plasma nicotine and self-reported craving were assessed at t = 0, 5, 15, 30, 60 and 90 minutes. The primary outcome was plasma nicotine concentration at t = 30 minutes. A secondary outcome was craving relief at t = 5 minutes.Findings: At t = 30, mean [95% confidence interval (CI)] plasma nicotine was 9.5 ng/ml (95% CI = 7.1, 11.9 ng/ml) for the 3 mg nicotine ONP, 17.5 ng/ml (95% CI = 13.7, 21.3) for the 6 mg nicotine ONP and 11.4 ng/ml (95% CI = 9.2, 13.6 ng/ml) for the cigarette. Mean plasma nicotine at t = 30 minutes differed between the 3- and 6-mg nicotine ONPs (P = 0.001) and between the 6-mg nicotine ONP and cigarette (P = 0.002). Mean (95% CI) craving at t = 5 minutes was lower for the cigarette (mean = 1.00, 95% CI = 0.61, 1.39) than either the 3 mg (mean = 2.25, 95% CI = 1.68, 2.82; P < 0.0001) or 6 mg nicotine (mean = 2.19, 95% CI = 1.60, 2.79; P < 0.0001) ONP.Conclusions: Among adult smokers, using 6-mg nicotine concentration oral nicotine pouches (ONPs) was associated with greater plasma nicotine delivery at 30 minutes than 3-mg ONPs or cigarettes, but neither ONP relieved craving symptoms at 5 minutes as strongly as a cigarette. Accelerating the speed of nicotine delivery in ONPs might increase their misuse liability relative to cigarettes.
引用
收藏
页码:464 / 475
页数:12
相关论文
共 36 条
  • [1] Characterization of the nicotine uptake and safety of Nordic spirit tobacco-free oral nicotine pouches: A randomized cross-over study
    Karine Renard
    Daisuke Nishihara
    Johan Nilsson
    Sylvain Larroque
    Javier Martinez
    Lesley Giles
    Psychopharmacology, 2025, 242 (4) : 855 - 865
  • [2] Qualitative perspective on nicotine pouches from adults who smoke cigarettes in North Carolina
    不详
    TOBACCO CONTROL, 2024,
  • [3] The Effects of Nicotine Pouches and E-Cigarettes on Oral Microbes: A Pilot Study
    Miluna-Meldere, Sintija
    Rostoka, Dagnija
    Broks, Renars
    Viksne, Kristine
    Ciematnieks, Rolands
    Skadins, Ingus
    Kroica, Juta
    MICROORGANISMS, 2024, 12 (08)
  • [4] A Descriptive Analysis of Beliefs About Nicotine and Switching to Noncombustibles Among Adults Who Smoke Cigarettes and Believe Nicotine Causes Cancer
    Weiger, Caitlin
    Kennedy, Ryan D.
    Villanti, Andrea C.
    Cohen, Joanna E.
    Moran, Meghan B.
    SUBSTANCE USE & MISUSE, 2024,
  • [5] Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
    Bullen, C.
    McRobbie, H.
    Thornley, S.
    Glover, M.
    Lin, R.
    Laugesen, M.
    TOBACCO CONTROL, 2010, 19 (02) : 98 - 103
  • [6] Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence
    Gerhard Scherer
    Nikola Pluym
    Max Scherer
    Harm Reduction Journal, 21 (1)
  • [7] E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial
    Cho, Yoo Jin
    Mehta, Toral
    Hinton, Alice
    Sloan, Ruth
    Nshimiyimana, Jean
    Tackett, Alayna P.
    Roberts, Megan E.
    Brinkman, Marielle C.
    Wagener, Theodore L.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [8] Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposure
    Yingst, Jessica M.
    Lester, Courtney
    Livelsberger, Craig
    Allen, Sophia I.
    Hammett, Erin
    Veldheer, Susan
    Hummer, Breianna
    Bordner, Candace
    Zhu, Junjia
    Sciamanna, Christopher N.
    Trushin, Neil
    Tan, Hock S.
    Wilson, Stephen J.
    Twining, Robert C.
    Foulds, Jonathan
    Grigson, Patricia Sue
    BRAIN RESEARCH BULLETIN, 2022, 188 : 30 - 37
  • [9] Using Pod Based e-Cigarettes and Nicotine Pouches to Reduce Harm for Adults With Low Socioeconomic Status Who Smoke: A Pilot Randomized Controlled Trial
    Avila, Jaqueline C.
    Maglalang, Dale Dagar
    Nollen, Nicole L.
    Lee, Sangah Clara
    Suh, Riley
    Malone, Mona
    Binjrajka, Urvi
    Ahluwalia, Jasjit S.
    NICOTINE & TOBACCO RESEARCH, 2024, 26 (09) : 1150 - 1158
  • [10] A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes
    Chapman, Fiona
    McDermott, Simon
    Rudd, Kathryn
    Taverner, Victoria
    Stevenson, Matthew
    Chaudhary, Nveed
    Reichmann, Kerstin
    Thompson, Joseph
    Nahde, Thomas
    O'Connell, Grant
    PSYCHOPHARMACOLOGY, 2022, 239 (09) : 2931 - 2943